Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

NCT01652092 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT01652092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01652092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 4, 2012
Completion date
December 31, 2026
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bare lymphocyte syndrome, cd40 ligand deficiency, chediak-higashi syndrome, chronic granulomatous disease, common variable immunodeficiency, griscelli syndrome, hemophagocytic lymphohistiocytosis, hyper igm syndrome, langerhan's cell histiocytosis, omenn's syndrome, reticular dysgenesis, scid, wiskott-aldrich syndrome, x-linked lymphoproliferative disease